Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 749698, 8 pages
http://dx.doi.org/10.1155/2014/749698
Research Article

The Societal Impact of Herpes Zoster and Postherpetic Neuralgia on Patients, Life Partners, and Children of Patients in Germany

1Klinikum Ernst von Bergmann, Gastroenterology and Infectious Disease, Charlottenstr 72, 14467 Potsdam, Germany
2GfK Healthcare, Nordwestring 101, 90419 Nurnberg, Germany
3Sanofi Pasteur MSD, 162 Avenue Jean Jaurès, CS 50712, 69367 Lyon Cedex 07, France

Received 3 October 2014; Accepted 9 November 2014; Published 8 December 2014

Academic Editor: Joav Merrick

Copyright © 2014 Thomas Weinke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Lungu, P. W. Annunziato, A. Gershon et al., “Reactivated and latent varicella-zoster virus in human dorsal root ganglia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 24, pp. 10980–10984, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Arvin, “Aging, immunity, and the varicella-zoster virus,” The New England Journal of Medicine, vol. 352, no. 22, pp. 2266–2267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. K. E. Schmader and R. H. Dworkin, “Natural history and treatment of herpes zoster,” The Journal of Pain, vol. 9, no. 1, pp. S3–S9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Schmader, J. W. Gnann Jr., and C. P. Watson, “The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine,” Journal of Infectious Diseases, vol. 197, no. 2, pp. S207–S215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. W. Johnson, D. Bouhassira, G. Kassianos, A. Leplège, K. E. Schmader, and T. Weinke, “The impact of herpes zoster and post-herpetic neuralgia on quality-of-life,” BMC Medicine, vol. 8, article 37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Drolet, M. Brisson, K. E. Schmader et al., “The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study,” CMAJ, vol. 182, no. 16, pp. 1731–1736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Weinke, A. Edte, S. Schmitt, and K. Lukas, “Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey,” Zeitschrift fur Gesundheitswissenschaften, vol. 18, pp. 367–374, 2010. View at Google Scholar
  8. D. Bouhassira, O. Chassany, J. Gaillat et al., “Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice,” Pain, vol. 153, no. 2, pp. 342–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Lukas, A. Edte, and I. Bertrand, “The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries,” Journal of Public Health, vol. 20, no. 4, pp. 441–451, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. van Seventer, A. Sadosky, M. Lucero, and E. Dukes, “A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia,” Age and Ageing, vol. 35, no. 2, pp. 132–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Coplan, K. Schmader, A. Nikas et al., “Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory,” Journal of Pain, vol. 5, no. 6, pp. 344–356, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Chidiac, J. Bruxelle, J.-P. Daures et al., “Characteristics of patients with herpes zoster on presentation to practitioners in France,” Clinical Infectious Diseases, vol. 33, no. 1, pp. 62–69, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Álvarez-Pasquín, M. L. Morató, A. Sampedro, M. San-Martín, and Grupo EPIZOSTER, “Perception of herpes zoster in the general population,” Vacunas, vol. 12, no. 3, pp. 86–94, 2011. View at Publisher · View at Google Scholar
  14. J. Knodel, “The design and analysis of focus group studies: a practical approach,” in Successful Focus Groups: Advancing the State of the Art, D. L. Morgan, Ed., pp. 35–50, Sage, Newbury Park, Calif, USA, 1993. View at Google Scholar
  15. J. T. Salvendy, “Selection and preparation of patients and organization of the group,” in Comprehensive Group Psychotherapy, H. I. Kaplan and B. J. Sadock, Eds., pp. 72–84, William & Wilkins, Baltimore, Md, USA, 3rd edition, 1993. View at Google Scholar
  16. D. S. Whitaker and M. D. Lieberman, Psychotherapy through the Group Process, Atherton Press, New York, NY, USA, 1964.
  17. I. D. Yalom, The Theory and Practice of Group Psychotherapy, Basic Books, New York, NY, USA, 3rd edition, 1985.
  18. J. Katz, E. M. Cooper, R. R. Walther, E. W. Sweeney, and R. H. Dworkin, “Acute pain in herpes zoster and its impact on health-related quality of life,” Clinical Infectious Diseases, vol. 39, no. 3, pp. 342–348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. K. E. Schmader, R. Sloane, C. Pieper et al., “The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults,” Clinical Journal of Pain, vol. 23, no. 6, pp. 490–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. V. Chua and W. H. Chen, “Herpes zoster vaccine for the elderly: boosting immunity,” Aging Health, vol. 6, no. 2, pp. 169–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. H. Dworkin, R. W. Johnson, J. Breuer et al., “Recommendations for the management of herpes zoster,” Clinical Infectious Diseases, vol. 44, supplement 1, pp. S1–S26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Gnann Jr. and R. J. Whitley, “Herpes zoster,” The New England Journal of Medicine, vol. 347, no. 5, pp. 340–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. R. W. Johnson, “Zoster-associated pain: what is known, who is at risk and how can it be managed?” Herpes, vol. 14, no. 2, pp. 30–34, 2007. View at Google Scholar · View at Scopus
  24. R. W. Johnson, G. Wasner, P. Saddier, and R. Baron, “Postherpetic neuralgia: epidemiology, pathophysiology and management,” Expert Review of Neurotherapeutics, vol. 7, no. 11, pp. 1581–1595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. R. G. Kost and S. E. Straus, “Postherpetic neuralgia—pathogenesis, treatment, and prevention,” The New England Journal of Medicine, vol. 335, no. 1, pp. 32–42, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. M. N. Oxman, M. J. Levin, G. R. Johnson et al., “A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults,” The New England Journal of Medicine, vol. 352, no. 22, pp. 2271–2365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. E. Schmader, M. N. Oxman, M. J. Levin et al., “Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy,” Clinical Infectious Diseases, vol. 55, no. 10, pp. 1320–1328, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. E. Schmader, G. R. Johnson, P. Saddier et al., “Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults,” Journal of the American Geriatrics Society, vol. 58, no. 9, pp. 1634–1641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Langan, L. Smeeth, D. J. Margolis, and S. L. Thomas, “Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study,” PLoS Medicine, vol. 10, no. 4, Article ID e1001420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. H. F. Tseng, A. Liu, L. Sy et al., “Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study,” Journal of Internal Medicine, vol. 271, no. 5, pp. 510–520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. H. F. Tseng, N. Smith, R. Harpaz, S. R. Bialek, L. S. Sy, and S. J. Jacobsen, “Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease,” The Journal of the American Medical Association, vol. 305, no. 2, pp. 160–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Zhang, F. Xie, E. Delzell et al., “Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases,” The Journal of the American Medical Association, vol. 308, no. 1, pp. 43–49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. G. L. Freed, S. J. Clark, A. T. Butchart, D. C. Singer, and M. M. Davis, “Sources and perceived credibility of vaccine-safety information for parents,” Pediatrics, vol. 127, supplement 1, pp. S107–S112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Hughes, J. R. Cates, N. Liddon, J. S. Smith, S. L. Gottlieb, and N. T. Brewer, “Disparities in how parents are learning about the human papillomavirus vaccine,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 2, pp. 363–372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Kennedy, M. Basket, and K. Sheedy, “Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey,” Pediatrics, vol. 127, no. 1, pp. S92–S99, 2011. View at Publisher · View at Google Scholar · View at Scopus